SynthesisFrontiers in oncology2022

Treatment- and immune-related adverse events of immune checkpoint inhibitors in esophageal or gastroesophageal junction cancer: A network meta-analysis of randomized controlled trials.

Jianqing Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.